Literature DB >> 19473786

Opioid use behaviors, mental health and pain--development of a typology of chronic pain patients.

Caleb J Banta-Green1, Joseph O Merrill, Suzanne R Doyle, Denise M Boudreau, Donald A Calsyn.   

Abstract

BACKGROUND: The intersection of pain, addiction and mental health has not been adequately described. We describe the roles of these three conditions in a chronic pain patient population using opioid analgesics. Aims were to improve our understanding of this population as well as to explore ways of identifying different types of patients.
METHODS: We conducted a retrospective cohort study in a large integrated group medical practice in Washington State with persons using opioids chronically (n=704). Patient classes were derived with latent class analysis using factors representing DSM-IV opioid abuse and dependence, opioid misuse, pain, anxiety and depression. Regression analyses explored the utility of automated and interview data to distinguish the empirically derived patient groups.
RESULTS: Three classes were identified: a Typical group, the substantial majority that had persistent, moderate mental health and pain symptoms; an Addictive Behaviors group with elevated mental health symptoms and opioid problems, but pain similar to the Typical class; and a Pain Dysfunction class with significantly higher pain interference as well as elevated mental health and opioid problems. Prescribed average daily dose of opioids was three times higher for those in the two atypical groups and was strongly associated with class membership after adjusting for other variables.
CONCLUSION: We describe three distinct types of patient classes as well as data elements that could help identify the two atypical types. Further research is needed to confirm these findings and determine the utility of this approach in other clinical settings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19473786      PMCID: PMC2716214          DOI: 10.1016/j.drugalcdep.2009.03.021

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  38 in total

1.  Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users.

Authors:  Neerav Monga; Jürgen Rehm; Benedikt Fischer; Suzanne Brissette; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Francesco Leri; Jean-Sébastien Fallu; Saira Bahl
Journal:  Drug Alcohol Depend       Date:  2006-10-17       Impact factor: 4.492

2.  Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates.

Authors:  William C Becker; Lynn E Sullivan; Jeanette M Tetrault; Rani A Desai; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2007-12-11       Impact factor: 4.492

3.  Substance use disorders in a primary care sample receiving daily opioid therapy.

Authors:  Michael F Fleming; Stacey L Balousek; Cynthia L Klessig; Marlon P Mundt; David D Brown
Journal:  J Pain       Date:  2007-05-11       Impact factor: 5.820

4.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

5.  Use of opioid medications for chronic noncancer pain syndromes in primary care.

Authors:  M Carrington Reid; Laura L Engles-Horton; MaryAnn B Weber; Robert D Kerns; Elizabeth L Rogers; Patrick G O'Connor
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

6.  Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment.

Authors:  Jodie A Trafton; Elizabeth M Oliva; Doyanne A Horst; Jared D Minkel; Keith Humphreys
Journal:  Drug Alcohol Depend       Date:  2004-01-07       Impact factor: 4.492

7.  Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R).

Authors:  Stephen F Butler; Kathrine Fernandez; Christine Benoit; Simon H Budman; Robert N Jamison
Journal:  J Pain       Date:  2008-01-22       Impact factor: 5.820

8.  Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities.

Authors:  Andrew Rosenblum; Herman Joseph; Chunki Fong; Steven Kipnis; Charles Cleland; Russell K Portenoy
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls.

Authors:  Jennifer R Mertens; Yun W Lu; Sujaya Parthasarathy; Charles Moore; Constance M Weisner
Journal:  Arch Intern Med       Date:  2003-11-10

10.  The Patient Health Questionnaire-2: validity of a two-item depression screener.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams
Journal:  Med Care       Date:  2003-11       Impact factor: 2.983

View more
  45 in total

1.  Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors.

Authors:  Kathleen W Saunders; Michael Von Korff; Cynthia I Campbell; Caleb J Banta-Green; Mark D Sullivan; Joseph O Merrill; Constance Weisner
Journal:  J Pain       Date:  2012-01-29       Impact factor: 5.820

Review 2.  Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews.

Authors:  Charl Els; Tanya D Jackson; Diane Kunyk; Vernon G Lappi; Barend Sonnenberg; Reidar Hagtvedt; Sangita Sharma; Fariba Kolahdooz; Sebastian Straube
Journal:  Cochrane Database Syst Rev       Date:  2017-10-30

3.  Prevalence and experience of chronic pain in suburban drug injectors.

Authors:  Robert Heimer; Weihai Zhan; Lauretta E Grau
Journal:  Drug Alcohol Depend       Date:  2015-03-19       Impact factor: 4.492

4.  Opioids and chronic pain in primary care.

Authors:  Steve Brinksman
Journal:  Br J Gen Pract       Date:  2018-10       Impact factor: 5.386

Review 5.  The drive to taper opioids: mind the evidence, and the ethics.

Authors:  Stefan G Kertesz; Ajay Manhapra
Journal:  Spinal Cord Ser Cases       Date:  2018-07-27

6.  Parallel modeling of pain and depression in prediction of relapse during buprenorphine and naloxone treatment: A finite mixture model.

Authors:  Noel A Vest; Sterling McPherson; G Leonard Burns; Sarah Tragesser
Journal:  Drug Alcohol Depend       Date:  2020-02-26       Impact factor: 4.492

7.  Gender and prescription opioids: findings from the National Survey on Drug Use and Health.

Authors:  Sudie E Back; Rebecca L Payne; Annie N Simpson; Kathleen T Brady
Journal:  Addict Behav       Date:  2010-06-22       Impact factor: 3.913

8. 

Authors:  Nav Persaud
Journal:  Can Fam Physician       Date:  2018-02-15       Impact factor: 3.275

9. 

Authors:  Nav Persaud
Journal:  Can Fam Physician       Date:  2018-02-15       Impact factor: 3.275

10.  Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain.

Authors:  M O Martel; A D Wasan; R N Jamison; R R Edwards
Journal:  Drug Alcohol Depend       Date:  2013-04-22       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.